Search

NEWS & REPORTS

Investor Relations

Investor Relations News

, Investors

Evonik is streamlining processes and reducing administrative and selling expenses


• Next step towards a performance-oriented corporate culture with a healthy cost structure
• Up to 1,000 jobs to be cut worldwide in administration and sales by year-end 2020
• Agreement with employee representatives on key points

More
, Investors

Evonik made a good start to 2018


• Adjusted EBITDA rises 14 percent to €679 million
• Sales increase 1 percent to €3.68 billion
• Full-year forecast confirmed

More
, Investors

Evonik invests in American skin technology start-up mySkin


• Evonik is driving digitalization in the cosmetic industry
• mySkin’s unique handheld device “OKU” measures a variety of skin properties and recommends care products
• Breakthrough in how consumers can measure and improve their skin

More
, Investors

Evonik to close its Kaba site in Hungary


Essen (Germany) / Kaba (Hungary). Evonik will stop its amino acid production at its Hungarian Kaba site by the end of April 2018. There Evonik Agroferm Zrt., a subsidiary of Evonik, currently employs about 120 people.

More
, Investors

Evonik plans new polyamide 12 complex in Marl


• Evonik's largest investment in Germany
• Targeted strengthening of the Resource Efficiency growth segment
• Strong growth for high-performance polymer polyamide 12 in the automotive sector, the oil and gas industry, and 3D printing

More
, Investors

A good performance in 2017


• Forecast fully achieved: Adjusted EBITDA of €2.36 billion is at the upper end of the range
• Outlook for 2018: Sales and earnings growth,
adjusted EBITDA between €2.4 billion and €2.6 billion
• Active portfolio management: Examining strategic options for the methacrylates business

More
more
Contact & Service

Contacts in the Investor Relations Depart-ment

more

Disclaimer

more